1 – 10 of 107
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2026
- Defining important aspects of repigmentation in vitiligo : insights from patients' perspectives (2026) PIGMENT CELL & MELANOMA RESEARCH. 39(2).
- Downregulated aryl hydrocarbon receptor expression is linked with increased IFN-γ production and impaired immune checkpoint upregulation in vitiligo (2026) JOURNAL OF INVESTIGATIVE DERMATOLOGY. 146(2). p.393-404.e1
- 2025
- A quality analysis of the measurement properties of the clinician-reported outcome measures for vitiligo and of the studies assessing them : a systematic review (2025) JOURNAL OF CLINICAL MEDICINE. 14(8).
- Quality analysis of measurement properties of patient-reported outcome measures for vitiligo and of the studies assessing them : a systematic review (2025) PIGMENT CELL & MELANOMA RESEARCH. 38(3).
- Reliability of measurement instruments for vitiligo extent and their feasibility : a meta-analysis (2025) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 39(10). p.e834-e837
- 2024
- Predictive value of disease activity signs in vitiligo : an observational study (2024) EXPERIMENTAL DERMATOLOGY. 33(9).
- Vitiligo : from pathogenesis to treatment (2024) JOURNAL OF CLINICAL MEDICINE. 13(17).
- Hot spots for clinical signs of disease activity in vitiligo (2024) EXPERIMENTAL DERMATOLOGY. 33(1).
- A meta-analysis of the placebo response in vitiligo : causes and consequences for the interpretation of clinical trials (2024) PIGMENT CELL & MELANOMA RESEARCH. 37(1). p.74-80
- The pathways in immune-mediated skin disorders : a guide for strategic treatment decisions (2024) IMMUNE NETWORK. 24(5).